01783nam a22002417a 450000500170000000800410001702200140005804000140007221000090008622200390009524500470013426000400018130000220022131000220024336200480026550003390031350502520065250502380090450501350114250501710127765000370144865000560148520260507115434.0260507b        |||||||| |||| 00| 0 eng d  a0261-1929  aMMSUcULS  aATLA  aAlternatives to Laboratory Animals  aATLA :bAlternatives to laboratory animals  aLondon: bSage Publications,c2025-  avolumes ;c28 cm.  aSix times a year.  aVolume 53, Number 5 (September 2025-      )  aATLA is a peer-reviewed journal, intended to cover all aspects of the development, validation, implementation and use of alternatives to laboratory animals in biomedical research and toxicity testing. In addition to the replacement of animals, it also covers work that aims to reduce the number of animals used and refine the in vivo   tCombinatorial induction with valproic acid and fibroblast growth factor-9 enhances neural differentiation and cell fate commitment in adipose tissue-derived mesenchymal stem cells (pp. 249–260)  /rLubna Khan, Nazia Ahmed, and Bushra Kiran Naeem  tMesoporous bioactive glass nanoparticles exhibit intrinsic angiogenic potential in the chorioallantoic membrane assay, without the addition of exogenous cells (pp. 261–270) /rMaximilian N. Moll, Qaisar Nawaz, and Fabian Westhauser  tThe Recombinant Antibodies & Mimetics Database: Redefining the future of antibody use in science (pp. 271–280) /rStephanie Modi  tBiosensor-based approaches: Exploring hapten–protein interactions for the prediction of skin sensitisation (pp. 281–300) /rTeh Ubaidah Noh and Nurul Izzah Khalid  aBiomedical researchvPeriodicals  aAnimals as alternatives in laboratoiesvPeriodicals